FindTrial
Sign In

Adverse Drug Reactions (ADRs) to Psychotropic Medications

A Spectrum of Rare Adverse Drug Reactions Associated with Psychotropic Medications: A Pharmacovigilance Case Series - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110356
Enrollment
3
Registered
2026-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F90-F98- Behavioral and emotional disorders with onset usually occurring in childhood and adolescence

Interventions

Intervention1: Nil: Nil

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: The single-center retrospective case series is based on cases identified from the Departments of Psychiatry and Medicine at a tertiary care teaching hospital. Clinical details were reviewed, and standard causality, severity, and preventability assessments were done. Patients who developed uncommon ADRs associated with psychotropic drugs were included.

Exclusion criteria

Exclusion criteria: Patients who did not develop ADRs to Psychotropic agents

Design outcomes

Primary

MeasureTime frame
To describe and analyze probable cases of Adverse Drug Reactions (ADRs) associated with psychotropic agents. To discuss their clinical course, causality assessment and management. Timepoint: These are adverse drug reactions, and patients were followed up for 3 months—

Secondary

MeasureTime frame
To do the ADR Causality AssessmentTimepoint: The ADR will be assessed at baseline, & the patients will be followed up for three months—

Countries

India

Contacts

Public ContactDr N HAMSINI

KIMS, Bangalore

drpriyanka110@gmail.com09844093100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026